MisterMoon
Re:
"Unfortunately you are taking a very narrow angle on the interaction noiprocs."
Perhaps not surprisingly, I disagree with you.
What I attempted to get across was the innapropriate way that you invited discussion on this topic.
Your inflammatory approach immediately took away any credibility you might have had, and said more about you as a person than the merits or otherwise of T4P's charting methods.
Fortunately, T4P had the good grace to elaborate and to assist the forum in understanding how his methods can be useful. I am not convinced that many others would have bothered.
I guess what I am saying is, Why can't you be cordial and respectful of others rather than abrasive and unpleasant?
Cheers
Nev
- Forums
- ASX - By Stock
- CVI
- credibility
credibility, page-67
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CVI (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online